pharmaphorum November 30, 2023
Phil Taylor

After five years of painstaking lab work, more than 350,000 hours of genome sequencing and £200 million ($253 million) in investment, UK Biobank has completed and released the full sequencing data from its 500,000 volunteers, which should become a rich resource for the discovery of new diagnostics and therapeutics.

The genomic data drop is said to be the largest that has ever been made available for research purposes and is being offered to scientists worldwide – providing they plan to use it for appropriate studies.

Crucially, the genome data is accompanied by 15 years of information from the patient cohort on lifestyle, whole-body imaging scans, biological samples and other health information that can be harnessed for research studies and, according...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article